血栓管理設備市場：按細分市場劃分的規模、份額、法規、報銷、程序、到 2033 年的預測

靜脈血栓栓塞（VTE）是指深部靜脈栓塞（DVT）和肺栓塞（PE）的術語。 當深層靜脈形成血塊，限制血流時，就會發生 DVT。 另一方面，如果血塊或血塊的一部分進入血流並到達肺部，則可能導致肺栓塞。 經皮機械血栓切除術透過抽吸、浸漬和/或破碎去除血塊或栓塞。 機械血栓切除術對於容易發生血栓溶解藥物副作用影響的患者非常有用。 直接導管溶栓是治療 DVT 和 PE 的常用血管內方法。 它也可用於沒有溶栓治療禁忌的患者。 此細分市場涵蓋血栓切除系統（導管）、手動抽吸血栓切除裝置、旋轉血栓切除裝置、栓子清除球囊裝置、標準導管直接溶栓導管（CDT）、超音波輔助導管直接溶栓導管。

本報告深入了解全球血栓管理設備市場，提供競爭格局、SWOT 分析、到 2033 年的市場預測、COVID-19 的影響、區域和國家趨勢等。

目錄

目前市面上血栓管理設備及競爭狀況

• 對主要產業趨勢的見解
• 2015 年至 2033 年血栓管理設備各細分市場的市場總收入及市場前景
• 按細分市場劃分的手術總數、單位數量、平均售價和市場價值的詳細數據

全球、區域與國家見解

• 血栓管理設備市場的SWOT分析
• 血栓管理設備市場的競爭動態洞察與趨勢
• 各國醫療保健系統概覽
• 按國家/地區劃分的報銷政策
• 各國醫療科技的監管狀況

Clot Management Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Clot Management Devices market for the year 2020 and beyond. Venous Thromboembolism (VTE) is a term that refers to Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). DVT occurs when a blood clot forms in the deep veins, which can result in restricted blood flow whereas when the clot or part of it migrates through the bloodstream and reaches the lungs, it causes a Pulmonary Embolism. Percutaneous Mechanical Thrombectomy removes the thrombus or emboli by aspiration, maceration and/or fragmentation. Mechanical Thrombectomy is useful in patients who are susceptible to the side effects of thrombolytic drugs. Catheter-Directed Thrombolysis is a commonly-used endovascular approach in the treatment of DVT and PE. It can be used in patients who are not contraindicated for Thrombolysis. Thrombectomy Systems (Catheters), Manual Aspiration Thrombectomy Devices, Rotational Thrombectomy Devices, Embolectomy Balloon Devices, Standard Catheter Directed Thrombolysis catheter (CDT) and Ultrasound-assisted Catheter Directed Thrombolysis catheter are segments that are covered in this market.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Clot Management Devices market and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Clot Management Devices market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Clot Management Devices market.
• Competitive dynamics insights and trends provided Clot Management Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Inari Medical Inc, Boston Scientific Corp, Penumbra Inc, Teleflex Inc, Edwards Lifesciences Corp, Medtronic Plc, Argon Medical Devices Inc, LeMaitre Vascular Inc, AngioDynamics Inc, Terumo Corp, Merit Medical Systems Inc, Cook Medical Inc, Koninklijke Philips NV, Control Medical Technology LLC, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Clot Management Devices market place to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Clot Management Devices market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Clot Management Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Clot Management Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Clot Management Devices market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable